Agenda

Daily Agendas

click on each date to view Agenda

July 22, 2020 July 23, 2020 July 24, 2020

July 22, 2020

WEAR GREEN DAY - #CCFAC2020

Time (MDT)	Event	Presenter
8:00-10:00am	Meet & Greet Activity	In Chat Room (not broadcast)
Morning Session
10:00-10:30am	Welcome to Conference/Cholangiocarcinoma Foundation Update	Stacie Lindsey, CCF
10:30-10:45am	Patient Perspective	Fred Koehl
10:45-11:00am	Volunteer Update & Recognition	Cindy Thomas, CCF
11:00-11:15am	Advocacy Update	Melinda Bachini, CCF
11:15-11:30am	CholangioConnect Update	Patty Maxin, CCF
11:30-11:45am	Philanthropy and Communications Update	Laura Hnat, CCF
11:45am-Noon	CCF Programming	Laura Hnat, CCF
Noon-12:30pm	Lunch Break	(not broadcast)
Early Afternoon Session
12:30-12:45pm	Caregiver Perspective	Randy Pike
12:45-1:00pm	Global Clinical Update	Rachna Shroff, University of Arizona
1:00-1:15pm	Global Research Update	Nabeel Bardeesy, Massachusetts General Hospital
1:15-2:15pm	Ciitizen	Sophia Cornrew, Ciitizen
2:15-2:30pm	Lunch Break	(not broadcast)
Late Afternoon Session
2:30-3:30pm	Financial Toxicity	Joanna Fawzy Morales, Triage Cancer
3:30-4:30pm	Breakout Session #1: Depression - Patients	Susan Ash-Lee, Cancer Support Community
4:30-5:30pm	Breakout Session #2: Depression - Caregivers	Dr. Geret Giles
5:15-5:30pm	Day 1 Closing	Stacie Lindsey, CCF

July 23, 2020

Time	Event	Presenter
Conference Welcome Day 2
8:00-8:15am	Conference Welcome	Jesús Banales, Biodonostia Institute, Spain
8:15-8:45am	CCF Update	Stacie Lindsey, CCF
8:45-9:00am	Patient Perspective	Tory Newmyer
Epidemiology from a Global Perspective, moderated by Tushar Patel, Mayo Clinic
9:00-9:15am	Asia	Li-Tzong Chen, Kaoshsiung Medicine University,Taiwan
9:15-9:30am	Europe	Juan Valle, NHS, UK
9:30-9:45am	USA	Aswin Chandakantran, Komodo Health
9:45-10:00am	Panel Discussion
10:00-10:15am	Break	(not broadcast)
Genetic Disposition for CCA, moderated by Anna Lleo, Humanitas University, Italy
10:15-10:45am	Incyte Survey Results	Kristen Bibeau, Incyte Corporation
10:45-11:00am	SNIPS and GWAS	Lewis Roberts, Mayo Clinic
11:00-11:15am	BRCA-DNA Repair and Alterations (Clinician Perspective)	Eileen O'Reilly, Memorial Sloan Kettering Cancer Center
11:15-11:30am	Diseases at Risk for CCA Development (PSC, Lynch, Alagille)	Chiara Braconi, Royal Marsden Hospital, UK
11:30-11:45am	Why is Perihilar More Frequent and Different Anatomically?	Greg Gores, Mayo Clinic
11:45am-Noon	Panel Discussion
Noon-12:30pm	Interactive Poster Session	(not broadcast)
Noon-12:30pm	Lunch	(not broadcast)
Consensus and Controversies in Animal Models, moderated by Chiara Raggi, University of Florence, Italy
12:30-12:45pm	In Vitro Studies	Nataliya Razumilava, University of Michigan
12:45-1:00pm	In Vivo Studies	Luke Boulter, University of Edinburgh, UK
1:00-1:15pm	NCI Patient Derived Models Repository (PDMR)	TBA
1:15-1:30pm	Panel Discussion
1:30-1:35pm	Short Break	(not broadcast)
Different Modalities for Profiling
1:35-1:50pm	Liquid Biopsy / Circulating Cells / DNA / Micro RNA	Jesus Banales, Biodonostia Institute, Spain
1:50-2:05pm	Deep Learning-Based Image Biomarkers for Cholangiocarcinoma	Jakob Nikolas Kather, University of Aachen, Germany
2:05-2:20pm	Circulating Tumor DNA for Targeted Therapy	Lipika Goyal, Mass. General Hospital
2:20-2:35pm	cBioPortal	Nikolaus Schultz, Memorial Sloan Kettering Cancer Center
2:35-2:50pm	Panel Discussion
2:50-3:00pm	Break	(not broadcast)
CCF Research Fellowship Reports - Nabeel Bardeesy
3:00-3:15pm	Caregiver Perspective	John McDonald
3:15-3:25pm	Understanding DKK1/GRP78 Interactions/Implications for Tumor Microenvironment	Edward Jarman, University of Edinburgh, UK	2019 Margaret M. Brown Award
3:25-3:35pm	Deciphering Role of IDH Mutant in Tumor Immune Microenvironment	Meng-Ju Wu, Mass. General Cancer Center	2019 Collaboration Award
3:35-3:45pm	Gut Microbiome-Dependent Accumulation of Myeloid Cells Promotes iCCA	Qianfei Zhang, National Cancer Institute	2019 Marion U. Schwartz Award
3:45-3:55pm	Developing FGFR2 Degrader with PROTAC Technology to Target iCCA	Tinghu Zhang, Dana-Farber Cancer Institute	2018 Andrea Lynn Scott Award
3:55-4:00pm	Day 2 Closing	Rachna Shroff, University of Arizona

July 24, 2020

Time (MDT)	Event	Presenter
Conference Welcome Day 3
8:00-8:15am	Conference Welcome	Rachna Shroff, University of Arizona
8:15-8:30am	Patient Perspective	TBA
8:30-9:00am	ICRN Update & New Initiatives	Mitesh Borad, Mayo Clinic
How can we Translate Novel Targets into the Clinic? moderated by John Gordon, UCSF
9:00-9:15am	HER2 Targeted Therapies	Kanwal Raghav, MD Anderson Cancer Center
9:15-9:30am	CDK46	Daniel Ahn, Mayo Clinic
9:30-9:45am	Methylation Targeting Agents	Jesper Anderson, University of Copenhagen, Denmark
9:45-10:00am	Panel Discussion
10:00-10:15am	Break	(not broadcast)
New Targets for Therapy and Drug Development
10:15-10:30am	Caregiver Perspective	Jessica Thomas
10:30-10:45am	How Can We Implement Translational Science into the Clinic?	Funda Meric-Bernstam, MD Anderson Cancer Center
10:45-11:00am	Cancer Metabolism	Patricia Aspichueta, University of the Basque Country, Spain
11:00-11:15am	Chemo Resistance	Rocio R. Macias, University of Salamanca, Spain
11:15-11:30am	Panel Discussion
11:30am-Noon	Memorial Tribute to Dr. Saha	Stacie Lindsey, CCF
Noon-12:30pm	Interactive Poster Session	(not broadcast)
Noon-12:30pm	Lunch Break	(not broadcast)
Clinical Trials, moderated by John Primrose, Southampton General Hospital, UK
12:30-1:45pm	Dietary Modification of the Tumor Microenvironment: New Frontiers in Cancer Research and Therapy	Introduction by Bruce Coppock Will Li, Angiogenesis Foundation
1:45-2:00pm	The Role of Neoadjuvant/Induction Treatment for BTC	Heinz Josef Klumpen, AmsterdamUMC, University of Amsterdam, Netherlands
2:00-2:15pm	What's on Horizon for All-Comer Studies?	Jennifer Knox, Princess Margaret Cancer Center, Canada
2:15-2:30pm	Cutting Edge Multi-Disciplinary Trials in RadOnc, Interventional Radiology	Eugene Koay, MD Anderson Cancer Center
2:30-2:45pm	Panel Discussion
2:45-2:50pm	Short Break	(not broadcast)
CCF Research Fellowship Reports - Katie Kelley
2:50-3:00pm	Investigating YAP Inhibition as a Novel Treatment for iCCA	Jacquelyn Russell, Boston Children's Hospital	2019 Mark R. Clements Award
3:00-3:10pm	B7-H3 Specific CAR T Cell Combinatorial Immunotherapy for iCCA	Theodorous Michelakos, Mass. General Cancer Center	2019 Jacques Dupont Award
3:10-3:20pm	Immunosuppressive Myeloid Cells Facilitate Tumor Progression	Emilien Loueuillard, Mayo Clinic	2019 Andrea Marie Fuquay Award
3:20-3:45pm	Break	(not broadcast)
How to Promote Translational Science: Opportunities for Collaboration, moderated by Luca Fabris, University of Padua, Italy
3:45-4:00pm	Asia
4:00-4:15pm	Europe	Jesus Banales, Biodonostia Institute, Spain
4:15-4:30pm	USA	Nabeel Bardeesy
4:30-4:45pm	Panel Discussion
4:45-5:00pm	Conference Closing	Jesús Banales, Rachna Shroff, Stacie Lindsey

updated 6/3/2020

Thanks to these sponsors, we are able to bring our conference to you...live and on demand.

Sequoia Level

Oak Level

Cedar Level

Maple Level

Funding for this conference was made possible (in part) by 1R13CA246934 from the National Cancer Institute. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention by trade names, commercial practices, or organizations imply endorsement by the U.S. Government.